Login / Signup

Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF): Results From the Advanced Gastric Cancer Expansion Cohort.

Kohei ShitaraMotohiro HiraoSatoru IwasaTakashi OshimaYoshito KomatsuAkihito KawazoeYasuyoshi SatoTakuya HamakawaKan YonemoriNozomu MachidaSatoshi YukiTakuya SuzukiShiori OkumuraTakao TakaseTaro SembaBob ZimmermannAngela TengKensei Yamaguchi
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
gov registration: NCT03207672.
Keyphrases
  • open label
  • metastatic breast cancer
  • neoadjuvant chemotherapy
  • phase ii
  • drug delivery
  • double blind
  • placebo controlled
  • clinical trial
  • locally advanced